About Elektrofi
Elektrofi is a company based in Boston (United States) founded in 2016 by Chase Coffman and Jason Norris was acquired by Halozyme in October 2025.. Elektrofi has raised $152.25 million across 4 funding rounds from investors including Lilly, Halozyme and Royalty Pharma. The company has 71 employees as of December 31, 2023. Elektrofi offers products and services including Hypercon Platform. Elektrofi operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Amunix, Biognosys and ProteinSimple, among others.
- Headquarter Boston, United States
- Employees 71 as on 31 Dec, 2023
- Founders Chase Coffman, Jason Norris
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Elektrofi, Inc.,
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elektrofi
Elektrofi offers a comprehensive portfolio of products and services, including Hypercon Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables hyper-concentrated microparticle delivery of biologic therapies subcutaneously
Unlock access to complete
Funding Insights of Elektrofi
Elektrofi has successfully raised a total of $152.25M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $112.25 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $112.3M
-
First Round
First Round
(01 Jul 2017)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series C - Elektrofi | Valuation | Novo Holdings , RA Capital Management | |
| Jun, 2022 | Amount | Series B - Elektrofi | Valuation | Marshall Wace , BVF Partners | |
| Sep, 2018 | Amount | Grant - Elektrofi | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elektrofi
Elektrofi has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Halozyme and Royalty Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Investments are made in marketed and late-stage biopharmaceutical companies.
|
Founded Year | Domain | Location | |
|
A biotechnology venture capital firm investing in innovative science.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elektrofi
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elektrofi
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elektrofi Comparisons
Competitors of Elektrofi
Elektrofi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Amunix, Biognosys and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Elektrofi
Frequently Asked Questions about Elektrofi
When was Elektrofi founded?
Elektrofi was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Elektrofi located?
Elektrofi is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Elektrofi?
Chase Coffman is the current CEO of Elektrofi. They have also founded this company.
Is Elektrofi a funded company?
Elektrofi is a funded company, having raised a total of $152.25M across 4 funding rounds to date. The company's 1st funding round was a Grant of $1.63M, raised on Jul 01, 2017.
How many employees does Elektrofi have?
As of Dec 31, 2023, the latest employee count at Elektrofi is 71.
What does Elektrofi do?
Elektrofi was founded in 2016 and is headquartered in Boston, United States. Operations focus on the biotechnology sector, where a digital platform is employed to advance the administration of biologic medicines. Proprietary Hypercon microparticle technology is integrated to formulate concentrated biologic drugs, allowing treatments to be delivered through straightforward subcutaneous injections rather than traditional methods.
Who are the top competitors of Elektrofi?
Elektrofi's top competitors include Somalogic, Nautilus Biotechnology and Biognosys.
What products or services does Elektrofi offer?
Elektrofi offers Hypercon Platform.
Who are Elektrofi's investors?
Elektrofi has 12 investors. Key investors include Lilly, Halozyme, Royalty Pharma, TPG, and Marshall Wace.